Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580008 · ClinicalTrials.gov registry record
Evaluation Using Computed Tomography Angiography (CTA) to Investigate and Detect Atherosclerotic Graft Disease (ELUCIDATE)
A clinical trial of Coronary Artery Disease and Arteriosclerosis of Coronary Artery Bypass Graft, sponsored by Corewell Health East.
- Completed
- Registry status
- 178
- Enrollment target
- 1
- Study location
NCT00580008: Completed study of Coronary Artery Disease and Arteriosclerosis of Coronary Artery Bypass Graft, sponsored by Corewell Health East.
NCT00580008 is a study of Coronary Artery Disease and Arteriosclerosis of Coronary Artery Bypass Graft that has completed, run by Corewell Health East. The registered enrollment target is 178 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00580008, a study of Coronary Artery Disease and Arteriosclerosis of Coronary Artery Bypass Graft, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- 178 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of clinical research is to look at the nature of disease and try to develop improved methods to diagnose and treat disease.The goal of this study is to evaluate the use of computed tomography (CT) scan of the heart in the diagnosis of disease in vein grafts after bypass surgery.
Primary Outcome
To identify the presence of and morphological characteristics of vein graft disease in patients at 1 and 2 years post bypass surgery.
Conditions Studied
Study Locations (1)
Michigan
- William Beaumont Hospital - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2007-12 |
| Est. Completion | 2011-08 |
What the finished NCT00580008 record still lists
NCT00580008 is an observational study that tracks outcomes without assigning an intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00580008 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00580008 about?
NCT00580008 is a clinical study titled "Evaluation Using Computed Tomography Angiography (CTA) to Investigate and Detect Atherosclerotic Graft Disease (ELUCIDATE)". The purpose of clinical research is to look at the nature of disease and try to develop improved methods to diagnose and treat disease.The goal of this study is to evaluate the use of computed tomography (CT) scan of the heart in the diagnosis of disease in vein grafts after bypass surgery.
What is the current status of trial NCT00580008?
This trial is currently completed. The enrollment target is 178 participants. The study started on 2007-12. Estimated completion is 2011-08.
What conditions does trial NCT00580008 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Arteriosclerosis of Coronary Artery Bypass Graft.
Who is sponsoring clinical trial NCT00580008?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00580008 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00580008's enrollment target sits among peer trials
178 126th of 219 higher than 94 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03642002 · 178 participants · NA
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
- NCT04227847 · 178 participants · Phase 1
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
- NCT04855214 · 178 participants
Evaluating the Experience of Upper Limb Prosthesis Use
- NCT05391126 · 178 participants · NA
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia